References
- Insel TR. Rethinking schizophrenia. Nature 2010;468:187–93.
- Seeman P, Lee T. Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons. Science 1975;188:1217–19.
- Beaulieu J-MM, Del’guidice T, Sotnikova TD, Lemasson M, Gainetdinov RR. Beyond cAMP: the regulation of Akt and GSK3 by dopamine receptors. Front Mol Neurosci 2011;4:38.
- Hu W, MacDonald ML, Elswick DE, Sweet RA. The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies. Ann N Y Acad Sci 2015;1338:38–57.
- Monji A, Kato T, Kanba S. Cytokines and schizophrenia: microglia hypothesis of schizophrenia. Psychiatry Clin Neurosci 2009;63:257–65.
- Crespo-Facorro B, Prieto C, Sainz J. Schizophrenia gene expression profile reverted to normal levels by antipsychotics. Int J Neuropsychopharmacol 2015;18:pyu066. doi: 10.1093/ijnp/pyu066.
- Spiegel I, Salomon D, Erne B, Schaeren-Wiemers N, Peles E. Caspr3 and caspr4, two novel members of the caspr family are expressed in the nervous system and interact with PDZ domains. Mol Cell Neurosci 2002;20:283–97.
- Chua SE, Cheung C, Cheung V, Tsang JT, Chen EY, Wong JC, et al. Cerebral grey, white matter and csf in never-medicated, first-episode schizophrenia. Schizophr Res 2007;89:12–21.
- Wagner G, Cruz F. D l, Schachtzabel C, Güllmar D, Schultz CC, Schlösser RG, et al. Structural and functional dysconnectivity of the fronto-thalamic system in schizophrenia: a DCM-DTI study. Cortex 2015;66:35–45.
- Cordon I, Nicolás MJJ, Arrieta S, Lopetegui E, López-Azcárate J, Alegre M, et al. Coupling in the cortico-basal ganglia circuit is aberrant in the ketamine model of schizophrenia. Eur Neuropsychopharmacol 2015;25:1375–87.
- Francis AN, Mothi SS, Mathew IT, Tandon N, Clementz B, Pearlson GD, et al. Callosal abnormalities across the psychosis dimension: bipolar schizophrenia network on intermediate phenotypes. Biol Psychiatry 2016;80:627--35.
- Hirata H, Takahashi A, Shimoda Y, Koide T. Caspr3-deficient mice exhibit low motor learning during the early phase of the accelerated rotarod task. PLoS One 2016;11:e0147887.
- Hirata H, Umemori J, Yoshioka H, Koide T, Watanabe K, Shimoda Y. Cell adhesion molecule contactin-associated protein 3 is expressed in the mouse basal ganglia during early postnatal stages. J Neurosci Res 2016;94:74–89.
- Rotarska-Jagiela A, Schönmeyer R, Oertel V, Haenschel C, Vogeley K, Linden DE. The corpus callosum in schizophrenia-volume and connectivity changes affect specific regions. Neuroimage 2008;39:1522–32.
- Womer FY, Wang L, Alpert KI, Smith MJ, Csernansky JG, Barch DM, et al. Basal ganglia and thalamic morphology in schizophrenia and bipolar disorder. Psychiatry Res 2014;223:75–83.
- Zampieri E, Bellani M, Crespo-Facorro B, Brambilla P. Basal ganglia anatomy and schizophrenia: the role of antipsychotic treatment. Epidemiol Psychiatr Sci 2014;23:333–6.
- Qiao YQ, Huang ML, Zheng Q, Wang TR, Xu AT, Cao Y, et al. CNTNAP3 associated ATG16L1 expression and Crohn's disease. Mediators Inflamm 2015;2015:404185.
- Merenlender-Wagner A, Shemer Z, Touloumi O, Lagoudaki R, Giladi E, Andrieux A, et al. New horizons in schizophrenia treatment: autophagy protection is coupled with behavioral improvements in a mouse model of schizophrenia. Autophagy 2014;10:2324–32.
- Merenlender-Wagner A, Malishkevich A, Shemer Z, Udawela M, Gibbons A, Scarr E, et al. Autophagy has a key role in the pathophysiology of schizophrenia. Mol Psychiatry 2015;20:126–32.